Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Journal of Personalized Medicine|April 28, 2023
Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD ExacerbationsKonstantinos Bartziokas, Evgenia Papathanasiou, Andriana I Papaioannou, et al.
In Vivo (Athens, Greece)|January 1, 2022
Early Occurrence of Adverse Events in Hospitalized Patients With COVID-19 and Beneficial Effect of AnticoagulationEvangelos Dimakakos, Anastasios Kollias, Vasiliki Rapti, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|March 16, 2021
Blood eosinophils as predictor of outcomes in patients hospitalized for COPD exacerbations: a prospective observational studyKonstantinos Kostikas, Evgenia Papathanasiou, Andriana I Papaioannou, et al.
Journal of Personalized Medicine|December 23, 2022
Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek CommunityNikolaos Tzanakis, Epameinontas Kosmas, Andriana I Papaioannou, et al.
Respiratory Medicine|October 4, 2016
Characterization of bronchiectasis in the elderlyGiuseppe Bellelli, James D Chalmers, Giovanni Sotgiu, et al.
Postgraduate Medicine|March 10, 2021
Device use errors among patients with asthma and COPD and the role of training: a real-life studyAndriana I Papaioannou, Konstantinos Bartziokas, Georgios Hillas, et al.
The European Respiratory Journal|February 2, 2018
The independent contribution of <i>Pseudomonas aeruginosa</i> infection to long-term clinical outcomes in bronchiectasisDavid Araújo, Michal Shteinberg, Stefano Aliberti, et al.
Chest|July 21, 2020
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired PneumoniaJudith Marin-Corral, Sergi Pascual-Guardia, Francesco Amati, et al.
The Lancet. Respiratory Medicine|September 13, 2024
Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 monthsCharles S Haworth, Michal Shteinberg, Kevin Winthrop, et al.
Annals of the American Thoracic Society|October 3, 2015
Etiology of Non-Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease SeveritySara Lonni, James D Chalmers, Pieter C Goeminne, et al.
Pageof 8